Transcript Daily logo

The Latest Headlines at Transcript Daily

Image about Tudor Investment Corp Et Al Takes Position in Rent-A-Center, Inc. (NASDAQ:RCII)

Tudor Investment Corp Et Al Takes Position in Rent-A-Center, Inc. (NASDAQ:RCII)

Tudor Investment Corp Et Al acquired a new stake in shares of Rent-A-Center, Inc. (NASDAQ:RCII) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm... More of this article »
Image about Tudor Investment Corp Et Al Acquires Shares of 9,177 Hologic, Inc. (NASDAQ:HOLX)

Tudor Investment Corp Et Al Acquires Shares of 9,177 Hologic, Inc. (NASDAQ:HOLX)

Tudor Investment Corp Et Al acquired a new stake in Hologic, Inc. (NASDAQ:HOLX) in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 9,177 shares of... More of this article »
Image about Tudor Investment Corp Et Al Acquires Shares of 139,382 Southwestern Energy (NYSE:SWN)

Tudor Investment Corp Et Al Acquires Shares of 139,382 Southwestern Energy (NYSE:SWN)

Tudor Investment Corp Et Al acquired a new stake in Southwestern Energy (NYSE:SWN) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 139,382 shares... More of this article »
Image about Tudor Investment Corp Et Al Sells 2,898 Shares of EdtechX Holdings Acquisition Corp. II (OTCMKTS:EDTXU)

Tudor Investment Corp Et Al Sells 2,898 Shares of EdtechX Holdings Acquisition Corp. II (OTCMKTS:EDTXU)

Tudor Investment Corp Et Al trimmed its holdings in EdtechX Holdings Acquisition Corp. II (OTCMKTS:EDTXU) by 4.1% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 67,102 shares of the company’s... More of this article »
Image about Head-To-Head Survey: Neogen (NASDAQ:NEOG) and Ortho Clinical Diagnostics (NASDAQ:OCDX)

Head-To-Head Survey: Neogen (NASDAQ:NEOG) and Ortho Clinical Diagnostics (NASDAQ:OCDX)

Neogen (NASDAQ:NEOG) and Ortho Clinical Diagnostics (NASDAQ:OCDX) are both mid-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations,... More of this article »
Image about Reviewing Tarsus Pharmaceuticals (NASDAQ:TARS) & Surface Oncology (NASDAQ:SURF)

Reviewing Tarsus Pharmaceuticals (NASDAQ:TARS) & Surface Oncology (NASDAQ:SURF)

Tarsus Pharmaceuticals (NASDAQ:TARS) and Surface Oncology (NASDAQ:SURF) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations,... More of this article »
Image about Tudor Investment Corp Et Al Invests $727,000 in Cardiovascular Systems, Inc. (NASDAQ:CSII)

Tudor Investment Corp Et Al Invests $727,000 in Cardiovascular Systems, Inc. (NASDAQ:CSII)

Tudor Investment Corp Et Al bought a new position in Cardiovascular Systems, Inc. (NASDAQ:CSII) during the first quarter, Holdings Channel reports. The fund bought 18,950 shares of the medical device company’s stock, valued... More of this article »
Image about Tudor Investment Corp Et Al Acquires New Holdings in Casella Waste Systems, Inc. (NASDAQ:CWST)

Tudor Investment Corp Et Al Acquires New Holdings in Casella Waste Systems, Inc. (NASDAQ:CWST)

Tudor Investment Corp Et Al acquired a new stake in shares of Casella Waste Systems, Inc. (NASDAQ:CWST) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC).... More of this article »
Image about Tudor Investment Corp Et Al Takes $705,000 Position in Abiomed, Inc. (NASDAQ:ABMD)

Tudor Investment Corp Et Al Takes $705,000 Position in Abiomed, Inc. (NASDAQ:ABMD)

Tudor Investment Corp Et Al purchased a new position in shares of Abiomed, Inc. (NASDAQ:ABMD) in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 2,212 shares... More of this article »
Image about PayPal (NASDAQ:PYPL) Receives “Hold” Rating from Needham & Company LLC

PayPal (NASDAQ:PYPL) Receives “Hold” Rating from Needham & Company LLC

Needham & Company LLC restated their hold rating on shares of PayPal (NASDAQ:PYPL) in a report issued on Thursday morning, Price Targets.com reports. Several other equities analysts have also commented on the stock. JMP Securities... More of this article »
Image about RBB Bancorp (NASDAQ:RBB) PT Raised to $27.50 at Stephens

RBB Bancorp (NASDAQ:RBB) PT Raised to $27.50 at Stephens

RBB Bancorp (NASDAQ:RBB) had its target price upped by Stephens from $25.50 to $27.50 in a report released on Thursday, Price Targets.com reports. The firm currently has an overweight rating on the stock. Other analysts also recently... More of this article »
Image about Wells Fargo & Company Trims Lam Research (NASDAQ:LRCX) Target Price to $660.00

Wells Fargo & Company Trims Lam Research (NASDAQ:LRCX) Target Price to $660.00

Lam Research (NASDAQ:LRCX) had its price target cut by Wells Fargo & Company from $690.00 to $660.00 in a research report released on Thursday, PriceTargets.com reports. They currently have an equal weight rating on the semiconductor... More of this article »
Image about SVB Leerink Boosts Pfizer (NYSE:PFE) Price Target to $49.00

SVB Leerink Boosts Pfizer (NYSE:PFE) Price Target to $49.00

Pfizer (NYSE:PFE) had its price objective hoisted by SVB Leerink from $47.00 to $49.00 in a report released on Thursday morning, Analyst Ratings Network reports. The brokerage currently has a market perform rating on the biopharmaceutical... More of this article »
Image about PBF Logistics (NYSE:PBFX) Releases Quarterly  Earnings Results, Beats Expectations By $0.05 EPS

PBF Logistics (NYSE:PBFX) Releases Quarterly Earnings Results, Beats Expectations By $0.05 EPS

PBF Logistics (NYSE:PBFX) issued its quarterly earnings results on Thursday. The pipeline company reported $0.59 EPS for the quarter, beating analysts’ consensus estimates of $0.54 by $0.05, MarketWatch Earnings reports. PBF... More of this article »
Image about Dana (NYSE:DAN) Issues FY21 Earnings Guidance

Dana (NYSE:DAN) Issues FY21 Earnings Guidance

Dana (NYSE:DAN) issued an update on its FY21 earnings guidance on Friday morning. The company provided EPS guidance of $2.10-2.60 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.43. The company issued revenue... More of this article »